• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮二尖瓣交界分离术后 20 年长期随访中的再介入治疗:重复经皮二尖瓣交界分离术的作用。

Reinterventions after percutaneous mitral commissurotomy during long-term follow-up, up to 20 years: the role of repeat percutaneous mitral commissurotomy.

机构信息

Cardiology Department, AP-HP, Bichat University Hospital, 46 rue Henri Huchard, Paris 75018, France.

出版信息

Eur Heart J. 2013 Jul;34(25):1923-30. doi: 10.1093/eurheartj/eht097. Epub 2013 Mar 20.

DOI:10.1093/eurheartj/eht097
PMID:23514935
Abstract

AIMS

We analysed reinterventions performed during long-term follow-up after percutaneous mitral commissurotomy (PMC) with a particular focus on freedom from mitral surgery and late results of repeat PMC.

METHODS AND RESULTS

In 912 patients who had good immediate results of PMC (valve area ≥1.5 cm² with mitral regurgitation ≤2/4), we analysed survival without reintervention (surgery or repeat PMC) and survival without surgery alone, with a follow-up up to 20 years. The median age was 48 years, and 251 patients (27%) had calcified valves. During a median follow-up of 12 years, 351 patients (38%) underwent a reintervention: surgery was performed in 266 (76%) patients and repeat PMC in 85 (24%). Cardiovascular survival without reintervention (surgery or repeat PMC) was 38 ± 2% at 20 years. When analysing cardiovascular survival without surgery, this rate increased to 46 ± 2% at 20 years. In the 504 patients aged <50 years at the time of their initial PMC, 20-year rates were 45 ± 3% for cardiovascular survival without reintervention and 57 ± 3% for cardiovascular survival without surgery. Of the 85 patients who underwent repeat PMC, cardiovascular survival without surgery was 60 ± 7% at 10 years.

CONCLUSION

After successful PMC, reintervention is frequently needed. However, almost half of the patients remained free from surgery at 20 years. Repeat PMC was performed in one out of four cases of reintervention in this study, thereby allowing for postponement of surgery in a substantial number of patients.

摘要

目的

我们分析了经皮二尖瓣交界切开术(PMC)后长期随访期间的再次介入治疗,特别关注二尖瓣手术的无复发率和再次 PMC 的晚期结果。

方法和结果

在 912 例 PMC 即时效果良好的患者(瓣口面积≥1.5cm²且二尖瓣反流≤2/4)中,我们分析了无再次介入(手术或再次 PMC)和无单纯手术的生存情况,并随访了长达 20 年。患者的中位年龄为 48 岁,251 例(27%)患者有钙化瓣膜。在中位随访 12 年后,351 例患者(38%)接受了再次介入治疗:266 例(76%)患者行手术治疗,85 例(24%)患者行再次 PMC。无再次介入(手术或再次 PMC)的心血管生存率在 20 年时为 38±2%。分析无手术的心血管生存率时,这一比率在 20 年时增加到 46±2%。在初始 PMC 时年龄<50 岁的 504 例患者中,无再次介入的心血管生存率为 20 年时 45±3%,无手术的心血管生存率为 57±3%。在再次接受 PMC 的 85 例患者中,无手术的心血管生存率在 10 年时为 60±7%。

结论

成功进行 PMC 后,再次介入治疗常常是必需的。然而,在 20 年时几乎有一半的患者无需手术。在本研究中,再次介入治疗中有四分之一的患者需要再次 PMC,从而使大量患者能够推迟手术。

相似文献

1
Reinterventions after percutaneous mitral commissurotomy during long-term follow-up, up to 20 years: the role of repeat percutaneous mitral commissurotomy.经皮二尖瓣交界分离术后 20 年长期随访中的再介入治疗:重复经皮二尖瓣交界分离术的作用。
Eur Heart J. 2013 Jul;34(25):1923-30. doi: 10.1093/eurheartj/eht097. Epub 2013 Mar 20.
2
Long-term efficacy of percutaneous mitral commissurotomy for restenosis after previous mitral commissurotomy.经皮二尖瓣交界分离术治疗二尖瓣交界分离术后再狭窄的长期疗效。
Heart. 2013 Sep;99(18):1336-41. doi: 10.1136/heartjnl-2013-303944. Epub 2013 Apr 27.
3
Relationship between valve calcification and long-term results of percutaneous mitral commissurotomy for rheumatic mitral stenosis.风湿性二尖瓣狭窄行经皮二尖瓣交界分离术的瓣膜钙化与长期疗效的关系。
Circ Cardiovasc Interv. 2014 Jun;7(3):381-9. doi: 10.1161/CIRCINTERVENTIONS.113.000858. Epub 2014 Apr 29.
4
Long-term follow-up of patients with percutaneous mitral commissurotomy.经皮二尖瓣交界切开术患者的长期随访
Kardiol Pol. 2008 May;66(5):525-30, discussion 531-2.
5
Mitral valve surgery after percutaneous mitral commissurotomy: is repair still feasible?经皮二尖瓣交界切开术后的二尖瓣手术:修复仍然可行吗?
Eur J Cardiothorac Surg. 2015 Jan;47(1):e1-6. doi: 10.1093/ejcts/ezu365.
6
Late outcome of percutaneous mitral commissurotomy: Randomized comparison of Inoue versus double-balloon technique.经皮二尖瓣交界切开术的远期疗效:Inoue 技术与双球囊技术的随机对照比较
Am Heart J. 2017 Dec;194:1-8. doi: 10.1016/j.ahj.2017.04.004. Epub 2017 Apr 18.
7
Immediate and mid-term results of repeat percutaneous mitral commissurotomy for restenosis following earlier percutaneous mitral commissurotomy.早期经皮二尖瓣交界切开术后再狭窄行重复经皮二尖瓣交界切开术的即刻及中期结果
Eur Heart J. 2000 Oct;21(20):1683-9. doi: 10.1053/euhj.1999.1992.
8
[Percutaneous mitral commissurotomy. 5-year results].[经皮二尖瓣交界切开术。5年随访结果]
Tunis Med. 2001 Nov;79(11):581-6.
9
Consequence of atrial fibrillation and the risk of embolism after percutaneous mitral commissurotomy: the necessity of the maze procedure.经皮二尖瓣交界切开术后房颤的后果及栓塞风险:迷宫手术的必要性。
Ann Thorac Surg. 2004 Sep;78(3):800-5; discussion 805-6. doi: 10.1016/j.athoracsur.2004.04.019.
10
Percutaneous balloon valvuloplasty compared with open surgical commissurotomy for mitral stenosis.经皮气囊瓣膜成形术与二尖瓣狭窄的直视外科交界切开术的比较
N Engl J Med. 1994 Oct 13;331(15):961-7. doi: 10.1056/NEJM199410133311501.

引用本文的文献

1
Reintervention after percutaneous mitral balloon commissurotomy in patients with rheumatic heart disease: feasibility of surgical mitral valve repair.风湿性心脏病患者经皮二尖瓣球囊成形术后的再次干预:二尖瓣手术修复的可行性
J Thorac Dis. 2025 Feb 28;17(2):593-602. doi: 10.21037/jtd-24-1485. Epub 2025 Feb 27.
2
[Catheter-based and surgical treatment of mitral valve diseases].[基于导管和手术的二尖瓣疾病治疗]
Inn Med (Heidelb). 2024 May;65(5):439-446. doi: 10.1007/s00108-024-01703-5. Epub 2024 Apr 10.
3
Papillary muscle rupture without severe mitral regurgitation following percutaneous balloon mitral commissurotomy: a case report.
经皮球囊二尖瓣交界切开术后乳头肌破裂但无严重二尖瓣反流:一例报告
Eur Heart J Case Rep. 2024 Feb 26;8(3):ytae114. doi: 10.1093/ehjcr/ytae114. eCollection 2024 Mar.
4
Scoring model based on cardiac CT and clinical factors to predict early good mitral valve repair in rheumatic mitral disease.基于心脏 CT 和临床因素的评分模型预测风湿性二尖瓣病变早期二尖瓣修复效果良好。
Eur Radiol. 2024 Aug;34(8):4963-4976. doi: 10.1007/s00330-023-10470-0. Epub 2024 Jan 22.
5
The 40th Anniversary of Percutaneous Balloon Valvuloplasty for Mitral Stenosis: Current Status.二尖瓣狭窄经皮球囊瓣膜成形术40周年:现状
Struct Heart. 2022 Sep 21;6(5):100087. doi: 10.1016/j.shj.2022.100087. eCollection 2022 Oct.
6
Left atrial size predicts long-term outcome after balloon mitral valvuloplasty.左心房大小可预测球囊二尖瓣成形术后的长期预后。
Cardiol J. 2023;30(5):753-761. doi: 10.5603/CJ.a2022.0092. Epub 2022 Oct 6.
7
2021 ESC/EACTS Guidelines for the management of valvular heart disease.2021年欧洲心脏病学会/欧洲心胸外科学会心脏瓣膜病管理指南。
EuroIntervention. 2022 Feb 4;17(14):e1126-e1196. doi: 10.4244/EIJ-E-21-00009.
8
Efficacy and safety of percutaneous mitral balloon valvotomy in patients with mitral stenosis: A systematic review and meta-analysis.经皮二尖瓣球囊瓣膜成形术治疗二尖瓣狭窄患者的疗效与安全性:一项系统评价与荟萃分析
Int J Cardiol Heart Vasc. 2021 Apr 1;33:100765. doi: 10.1016/j.ijcha.2021.100765. eCollection 2021 Apr.
9
Endovascular Therapy for Rheumatic Mitral and Aortic Valve Disease: Review Article.风湿性二尖瓣和主动脉瓣疾病的血管内治疗:综述文章
Curr Treat Options Cardiovasc Med. 2018 Jun 22;20(7):59. doi: 10.1007/s11936-018-0647-6.
10
Predictors of Long-Term Outcomes of Percutaneous Mitral Valvuloplasty in Patients with Rheumatic Mitral Stenosis.风湿性二尖瓣狭窄患者经皮二尖瓣球囊成形术长期预后的预测因素
Yonsei Med J. 2018 Mar;59(2):273-278. doi: 10.3349/ymj.2018.59.2.273.